Citation: B. Ljungberg et al., SERUM INTERLEUKIN-6 IN RELATION TO ACUTE-PHASE REACTANTS AND SURVIVALIN PATIENTS WITH RENAL-CELL CARCINOMA, European journal of cancer, 33(11), 1997, pp. 1794-1798
Citation: K. Grankvist et al., EVALUATION OF 5 GLYCOPROTEIN TUMOR-MARKERS (CEA, CA-50, CA-19-9, CA-125, CA-15-3) FOR THE PROGNOSIS OF RENAL-CELL CARCINOMA, International journal of cancer, 74(2), 1997, pp. 233-236
Citation: T. Rasmuson et al., SOLUBLE ECTODOMAIN OF C-ERBB-2 ONCOPROTEIN IN RELATION TO TUMOR STAGEAND GRADE IN HUMAN RENAL-CELL CARCINOMA, British Journal of Cancer, 75(11), 1997, pp. 1674-1677
Citation: T. Rasmuson et al., SERUM BETA(2)-MICROGLOBULIN AND PROGNOSIS OF PATIENTS WITH RENAL-CELLCARCINOMA, Acta oncologica, 35(4), 1996, pp. 479-482
Citation: T. Rasmuson et al., EXPRESSION OF THE HER-2 NEU ONCOPROTEIN IN SERUM IN PATIENTS WITH RENAL-CELL CARCINOMA/, European journal of cancer, 31A, 1995, pp. 454-454
Citation: T. Rasmuson et Gr. Bjork, URINARY-EXCRETION OF PSEUDOURIDINE AND PROGNOSIS OF PATIENTS WITH MALIGNANT-LYMPHOMA, Acta oncologica, 34(1), 1995, pp. 61-67
Citation: T. Rasmuson et al., FALSE-POSITIVE PROSTATE-SPECIFIC ANTIGEN VALUES IN THE SERA OF WOMEN WITH RENAL-CELL CARCINOMA, The Journal of urology, 151(3), 1994, pp. 704-705